BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33803489)

  • 1. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
    Wagmann L; Vollmer AC; Lauder L; Mahfoud F; Meyer MR
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence.
    Richter LHJ; Jacobs CM; Mahfoud F; Kindermann I; Böhm M; Meyer MR
    Anal Chim Acta; 2019 Sep; 1070():69-79. PubMed ID: 31103169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers - drug classes with low adherence in antihypertensive therapy.
    Ritscher S; Hoyer M; Wunder C; Obermüller N; Toennes SW
    Sci Rep; 2019 Oct; 9(1):15652. PubMed ID: 31666620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy.
    Ritscher S; Hoyer M; Georges C; Wunder C; Wallemacq P; Persu A; Obermüller N; Toennes SW
    PLoS One; 2020; 15(8):e0237383. PubMed ID: 32776967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment.
    Punt AM; Stienstra NA; van Kleef MEA; Lafeber M; Spiering W; Blankestijn PJ; Bots ML; van Maarseveen EM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():103-110. PubMed ID: 31146083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC-MS/MS.
    van der Nagel BCH; Versmissen J; Bahmany S; van Gelder T; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():367-373. PubMed ID: 28666228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.
    Ritscher S; Georges C; Wunder C; Wallemacq P; Persu A; Toennes SW
    Blood Press; 2020 Oct; 29(5):291-298. PubMed ID: 32400211
    [No Abstract]   [Full Text] [Related]  

  • 9. UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients.
    De Nicolò A; Avataneo V; Rabbia F; Bonifacio G; Cusato J; Tomasello C; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2016 Sep; 129():535-541. PubMed ID: 27497654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MS.
    Jacobs CM; Kunz M; Mahfoud F; Wagmann L; Meyer MR
    Anal Chim Acta; 2021 Dec; 1187():339137. PubMed ID: 34753562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of olmesartan and amlodipine in human plasma and urine by ultra performance liquid chromatography tandem mass spectrometry.
    Qi W; Zhao Q; Jiang J; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():27-34. PubMed ID: 24036499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
    Peeters LEJ; Feyz L; Hameli E; Zwart T; Bahmany S; Daemen J; van Gelder T; Versmissen J; Koch BCP
    Ther Drug Monit; 2020 Jun; 42(3):460-467. PubMed ID: 31593031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIXED DOSE COMBINATIONS WITH SELECTIVE BETA-BLOCKERS: QUANTITATIVE DETERMINATION IN BIOLOGICAL FLUIDS.
    Mahu ŞC; Hăncianu M; Agoroaei L; Grigoriu IC; Strugaru AM; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):585-91. PubMed ID: 26204671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of UHPLC-MS/MS methods to quantify 25 antihypertensive drugs in serum in a cohort of patients treated for hypertension.
    Thorstensen CW; Clasen PE; Rognstad S; Haldsrud R; Føreid S; Helstrøm T; Bergland OU; Halvorsen LV; Aune A; Olsen E; Brobak KM; Høieggen A; Gustavsen I; Larstorp ACK; Søraas CL; Opdal MS
    J Pharm Biomed Anal; 2022 Sep; 219():114908. PubMed ID: 35803015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing the gap - development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LC-HRMS/MS for adherence monitoring of antihypertensive drugs.
    Jacobs CM; Kunz M; Mahfoud F; Wagmann L; Meyer MR
    Anal Bioanal Chem; 2023 Jan; 415(1):167-177. PubMed ID: 36318313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel 'Dilute-and-Shoot' Liquid Chromatography-Tandem Mass Spectrometry Method for the Screening of Antihypertensive Drugs in Urine.
    Lawson AJ; Shipman KE; George S; Dasgupta I
    J Anal Toxicol; 2016; 40(1):17-27. PubMed ID: 26333988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
    Taus F; Gottardo R; Ballotari M; Utzeri C; Tagliaro F
    Drug Test Anal; 2022 Oct; 14(10):1773-1778. PubMed ID: 35855505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence: A Meta-Analysis.
    Groenland EH; van Kleef MEAM; Bots ML; Visseren FLJ; van der Elst KCM; Spiering W
    Hypertension; 2021 Jan; 77(1):85-93. PubMed ID: 33249865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of 21 antihypertensive drugs in serum using UHPLC-MS/MS.
    Gundersen POM; Helland A; Spigset O; Hegstad S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():84-93. PubMed ID: 29783197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.